Special Educational Needs: support in England
An overview of the current system of support for children and young people with special educational needs, and pressure on the system
A Westminster Hall debate on Paediatric Acute-onset Neuropsychiatric Syndrome and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections has been scheduled for 12 September. The debate will be opened by Wendy Chamberlain MP.
Debate on Pediatric Acute-onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (187 KB , PDF)
Some children develop a range of behavioural, emotional and physical symptoms following an infection. These can include symptoms of obsessive compulsive disorder, restricted eating and tics.
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) are diagnoses that have been proposed to explain the sudden development of these symptoms.
Currently, there is no overall medical consensus about the definition of these conditions and cause of these symptoms in children.
Diagnostic criteria and treatment options for PANS and PANDAS have been proposed by researchers and clinicians, but are based on limited evidence and many have called for more research.
There is currently no guidance on the diagnosis and treatment of these conditions in the NHS.
In 2022, the PANS PANDAS Working Group (PPWG) was established. This group includes representatives from healthcare professional bodies and royal colleges, the PANS PANDAS UK charity, and patients and their families. It aims to develop recommendations to reduce variation in, and improve, the diagnosis and treatment of children who present with acute-onset neuropsychiatric symptoms in the NHS.
Debate on Pediatric Acute-onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (187 KB , PDF)
An overview of the current system of support for children and young people with special educational needs, and pressure on the system
A briefing on the licensing, regulation and supply of new weight loss medications in England.
A debate has been scheduled in Westminster Hall for 3pm on 23 January on innovation in the field of rare retinal disease. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.